BOLY-KY Announces Establishment of Mainland China Grandchild Company via Subsidiary SUREWIN WORLDWIDE LIMITED
BOLY-KY, through its subsidiary SUREWIN WORLDWIDE LIMITED, announced the establishment of a new grandchild company, 'Zhejiang Boly Aerospace Technology Co., Ltd.' (tentative name), in mainland China, with an investment of 70 million RMB, focusing on carbon fiber medical devices and aerospace components, aiming to expand the Chinese market.
📋 Article Processing Timeline
- 📰 Published: May 6, 2026 at 09:00
- 🔍 Collected: May 7, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 7, 2026 at 09:13 (1h 13m after Collected)
1. Date of occurrence of the event: From 2026/5/6 to 2026/5/6
2. Method of new (or decreased) investment: 100% indirectly held by the company
3. Date of board resolution: 2026/5/6
4. Other approval dates: Not applicable
5. Quantity, unit price, and total amount of the transaction: Estimated investment amount is RMB 70 million, to be invested in phases.
6. Name of the invested company in mainland China: Zhejiang Boly Aerospace Technology Co., Ltd. (tentative)
7. Paid-in capital of the aforementioned invested company in mainland China: It is a newly established grandchild company, current paid-in capital is RMB 0.
8. Planned new capital of the aforementioned invested company in mainland China: Estimated investment amount is RMB 70 million.
9. Main business items of the aforementioned invested company in mainland China: Carbon fiber medical devices and aerospace components.
10. Type of auditor's opinion on the financial statements of the aforementioned invested company in mainland China for the most recent year: Not applicable, as it is a newly established grandchild company.
11. Total equity of the financial statements of the aforementioned invested company in mainland China for the most recent year: Not applicable, as it is a newly established grandchild company.
12. Profit/loss amount of the financial statements of the aforementioned invested company in mainland China for the most recent year: Not applicable, as it is a newly established grandchild company.
13. Actual investment amount in the aforementioned invested company in mainland China to date: It is a newly established grandchild company, current paid-in capital is RMB 0.
14. Counterparty and its relationship with the company: A grandchild company 100% held by the company.
15. If the counterparty is a related party, the reasons for selecting the related party as the transaction counterparty, the previous owner, the relationship between the previous owner and the company and the counterparty, the previous transfer date and transfer amount shall also be disclosed: Not applicable.
16. If the transacted object's ownership belonged to a related party within the past five years, the dates of acquisition and disposal by the related party, prices, and relationship with the company at the time of the transaction shall also be disclosed: Not applicable.
17. Disposal gains (or losses): Not applicable.
18. Delivery or payment terms (including payment period and amount), contract restrictions, and other important agreements: To be handled after approval by the competent authority.
19. Decision-making method, basis for price determination, and decision-making unit for this transaction: Board of Directors.
20. Broker: Not applicable.
21. Specific purpose of acquisition or disposal: Expand mainland China market.
22. Opinions of dissenting directors on this transaction: None.
23. This transaction is a related party transaction: Yes.
24. Date of approval by supervisors or audit committee: 2026/05/06.
25. Total approved investment in mainland China by Investment Commission (including this investment) to date: Not applicable.
26. Ratio of total approved investment in mainland China (including this investment) to paid-in capital in the most recent financial statements: Not applicable.
27. Ratio of total approved investment in mainland China (including this investment) to total assets in the most recent financial statements: Not applicable.
28. Ratio of total approved investment in mainland China (including this investment) to equity attributable to owners of the parent in the most recent financial statements: Not applicable.
29. Total actual investment in mainland China to date: Not applicable.
30. Ratio of total actual investment in mainland China to paid-in capital in the most recent financial statements: Not applicable.
31. Ratio of total actual investment in mainland China to total assets in the most recent financial statements: Not applicable.
32. Ratio of total actual investment in mainland China to equity attributable to owners of the parent in the most recent financial statements: Not applicable.
33. Recognized profit/loss from investment in mainland China for the most recent three years: 2023: NTD 286,636 thousand; 2024: NTD 462,874 thousand; 2025: NTD 375,581 thousand.
34. Amount of profits remitted back in the most recent three years: None.
35. Accountant's non-reasonable opinion on this transaction: Not applicable.
36. Accounting firm name: None.
37. Accountant's name: None.
38. Accountant's license number: None.
39. Date of previous material information disclosure on the same event: Not applicable.
40. Other matters to be specified: None.
Keywords: Material Information
2. Method of new (or decreased) investment: 100% indirectly held by the company
3. Date of board resolution: 2026/5/6
4. Other approval dates: Not applicable
5. Quantity, unit price, and total amount of the transaction: Estimated investment amount is RMB 70 million, to be invested in phases.
6. Name of the invested company in mainland China: Zhejiang Boly Aerospace Technology Co., Ltd. (tentative)
7. Paid-in capital of the aforementioned invested company in mainland China: It is a newly established grandchild company, current paid-in capital is RMB 0.
8. Planned new capital of the aforementioned invested company in mainland China: Estimated investment amount is RMB 70 million.
9. Main business items of the aforementioned invested company in mainland China: Carbon fiber medical devices and aerospace components.
10. Type of auditor's opinion on the financial statements of the aforementioned invested company in mainland China for the most recent year: Not applicable, as it is a newly established grandchild company.
11. Total equity of the financial statements of the aforementioned invested company in mainland China for the most recent year: Not applicable, as it is a newly established grandchild company.
12. Profit/loss amount of the financial statements of the aforementioned invested company in mainland China for the most recent year: Not applicable, as it is a newly established grandchild company.
13. Actual investment amount in the aforementioned invested company in mainland China to date: It is a newly established grandchild company, current paid-in capital is RMB 0.
14. Counterparty and its relationship with the company: A grandchild company 100% held by the company.
15. If the counterparty is a related party, the reasons for selecting the related party as the transaction counterparty, the previous owner, the relationship between the previous owner and the company and the counterparty, the previous transfer date and transfer amount shall also be disclosed: Not applicable.
16. If the transacted object's ownership belonged to a related party within the past five years, the dates of acquisition and disposal by the related party, prices, and relationship with the company at the time of the transaction shall also be disclosed: Not applicable.
17. Disposal gains (or losses): Not applicable.
18. Delivery or payment terms (including payment period and amount), contract restrictions, and other important agreements: To be handled after approval by the competent authority.
19. Decision-making method, basis for price determination, and decision-making unit for this transaction: Board of Directors.
20. Broker: Not applicable.
21. Specific purpose of acquisition or disposal: Expand mainland China market.
22. Opinions of dissenting directors on this transaction: None.
23. This transaction is a related party transaction: Yes.
24. Date of approval by supervisors or audit committee: 2026/05/06.
25. Total approved investment in mainland China by Investment Commission (including this investment) to date: Not applicable.
26. Ratio of total approved investment in mainland China (including this investment) to paid-in capital in the most recent financial statements: Not applicable.
27. Ratio of total approved investment in mainland China (including this investment) to total assets in the most recent financial statements: Not applicable.
28. Ratio of total approved investment in mainland China (including this investment) to equity attributable to owners of the parent in the most recent financial statements: Not applicable.
29. Total actual investment in mainland China to date: Not applicable.
30. Ratio of total actual investment in mainland China to paid-in capital in the most recent financial statements: Not applicable.
31. Ratio of total actual investment in mainland China to total assets in the most recent financial statements: Not applicable.
32. Ratio of total actual investment in mainland China to equity attributable to owners of the parent in the most recent financial statements: Not applicable.
33. Recognized profit/loss from investment in mainland China for the most recent three years: 2023: NTD 286,636 thousand; 2024: NTD 462,874 thousand; 2025: NTD 375,581 thousand.
34. Amount of profits remitted back in the most recent three years: None.
35. Accountant's non-reasonable opinion on this transaction: Not applicable.
36. Accounting firm name: None.
37. Accountant's name: None.
38. Accountant's license number: None.
39. Date of previous material information disclosure on the same event: Not applicable.
40. Other matters to be specified: None.
Keywords: Material Information